130 related articles for article (PubMed ID: 21302811)
1. Mutations in the HD and PEST domain of Notch-1 receptor in T-cell acute lymphoblastic leukemia: report of novel mutations from Indian population.
Bhanushali AA; Babu S; Thangapandi VR; Pillai R; Chheda P; Das BR
Oncol Res; 2010; 19(2):99-104. PubMed ID: 21302811
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of NOTCH1 mutation in adult T-cell acute lymphoblastic leukemia].
Lin ZK; Zhang R; Ge Z; Liu J; Guo X; Qiao C; Wu YJ; Qiu HR; Zhang JF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1403-8. PubMed ID: 24370020
[TBL] [Abstract][Full Text] [Related]
3. NOTCH1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.
Natarajan V; Bandapalli OR; Rajkumar T; Sagar TG; Karunakaran N
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e23-30. PubMed ID: 25493453
[TBL] [Abstract][Full Text] [Related]
4. PEST domain NOTCH mutations confer a poor relapse free survival in pediatric T-ALL: Data from a tertiary care centre in India.
Bhatia P; Totadri S; Singh M; Sharma P; Trehan A; Bansal D; Jain R; Varma N; Sachdeva MS; Patra N
Blood Cells Mol Dis; 2020 May; 82():102419. PubMed ID: 32179411
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway.
Gallo Llorente L; Luther H; Schneppenheim R; Zimmermann M; Felice M; Horstmann MA
Pediatr Blood Cancer; 2014 May; 61(5):788-96. PubMed ID: 24249312
[TBL] [Abstract][Full Text] [Related]
6. Significance of NOTCH1 mutations détections in T-acute lymphoblastic leukemia patients.
Aref S; El Agdar M; Salama O; Zeid TA; Sabry M
Cancer Biomark; 2020; 27(2):157-162. PubMed ID: 31796666
[TBL] [Abstract][Full Text] [Related]
7. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
[TBL] [Abstract][Full Text] [Related]
9. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
[TBL] [Abstract][Full Text] [Related]
10. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG
Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100
[TBL] [Abstract][Full Text] [Related]
11. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
12. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
[TBL] [Abstract][Full Text] [Related]
13. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
14. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
[TBL] [Abstract][Full Text] [Related]
15. The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.
Abualhaj NZ; Dardas Z; Azab B; Ali D; Sughayer MA; Aladily TN; Ahram M
Ann Diagn Pathol; 2019 Apr; 39():53-58. PubMed ID: 30718223
[TBL] [Abstract][Full Text] [Related]
16. [Research advance on the pathogenesis of T-ALL induced by notch 1 activating mutations].
Xu SN; Chen JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):242-5. PubMed ID: 20137156
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
[No Abstract] [Full Text] [Related]
18. CAD204520 Targets
Pagliaro L; Cerretani E; Vento F; Montanaro A; Moron Dalla Tor L; Simoncini E; Giaimo M; Gherli A; Zamponi R; Tartaglione I; Lorusso B; Scita M; Russo F; Sammarelli G; Todaro G; Silini EM; Rigolin GM; Quaini F; Cuneo A; Roti G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255842
[No Abstract] [Full Text] [Related]
19. Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
Valliyammai N; Nancy NK; Sagar TG; Rajkumar T
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e1-e8. PubMed ID: 29200162
[TBL] [Abstract][Full Text] [Related]
20. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
